The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
L -acetylcarnitine causes rapid antidepressant effects through the epigenetic induction of mGlu2 receptors
Open accessAbstract
Epigenetic mechanisms are involved in the pathophysiology of depressive disorders and are unique potential targets for therapeutic intervention. The acetylating agent L -acetylcarnitine (LAC), a well-tolerated drug, behaves as an antidepressant by the epigenetic regulation of type 2 metabotropic glutamate (mGlu2) receptors. It caused a rapid and long-lasting antidepressant effect in Flinders Sensitive Line rats and in mice exposed to chronic unpredictable stress, which, respectively, model genetic and environmentally induced depression. In both models, LAC increased levels of acetylated H3K27 bound to the Grm2 promoter and also increased acetylation of NF-ĸB-p65 subunit, thereby enhancing the transcription of Grm2 gene encoding for the mGlu2 receptor in hippocampus and prefrontal cortex. Importantly, LAC reduced the immobility time in the forced swim test and increased sucrose preference as early as 3 d of treatment, whereas 14 d of treatment were needed for the antidepressant effect of chlorimipramine. Moreover, there was no tolerance to the action of LAC, and the antidepressant effect was still seen 2 wk after drug withdrawal. Conversely, NF-ĸB inhibition prevented the increase in mGlu2 expression induced by LAC, whereas the use of a histone deacetylase inhibitor supported the epigenetic control of mGlu2 expression. Finally, LAC had no effect on mGlu2 knockout mice exposed to chronic unpredictable stress, and a single injection of the mGlu2/3 receptor antagonist LY341495 partially blocked LAC action. The rapid and long-lasting antidepressant action of LAC strongly suggests a unique approach to examine the epigenetic hypothesis of depressive disorders in humans, paving the way for more efficient antidepressants with faster onset of action.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epigenetic programming by maternal behavior
Weaver, I. C. G., Cervoni, N., Champagne, F. A., D'Alessio, A. C., Sharma, S., Seckl, J. R., Dymov, S., Szyf, M., & Meaney, M. J. (2004) · Nature Neuroscience · doi:10.1038/nn1276 · Cited by 6,177
The molecular neurobiology of depression
Krishnan, V., & Nestler, E. J. (2008) · Nature · doi:10.1038/nature07455 · Cited by 2,889
Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action
Tsankova, N. M., Berton, O., Renthal, W., Kumar, A., Neve, R. L., & Nestler, E. J. (2006) · Nature Neuroscience · doi:10.1038/nn1659 · Cited by 1,780
Ownby, R. L., Crocco, E., Acevedo, A., John, V., & Loewenstein, D. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.5.530 · Cited by 1,493 · cited 1×
“As yet, approximately 40% of patients are considered treatment resistant, and all current antidepressants require at least 2–3 wk to significantly improve mood, leaving severely ill patients at risk for suicide in the early phases of treatment (1) andmore likely to develop coronary artery disease, type 2 diabetes, and…”
BackgroundThe stressed synapse: the impact of stress and glucocorticoids on glutamate transmission
Popoli, M., Yan, Z., McEwen, B. S., & Sanacora, G. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3138 · Cited by 1,393
Sen, S., Duman, R., & Sanacora, G. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.05.005 · Cited by 1,232
Duration of Nuclear NF-κB Action Regulated by Reversible Acetylation
Chen, L.-F., Fischle, W., Verdin, E., & Greene, W. C. (2001) · Science · doi:10.1126/science.1062374 · Cited by 1,222
Shimizu, E., Hashimoto, K., Okamura, N., Koike, K., Komatsu, N., Kumakiri, C., Nakazato, M., Watanabe, H., Shinoda, N., Okada, S.-I., et al. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00181-1 · Cited by 1,151 · cited 1×
“BNDF levels are also reduced in the serum of depressed patients and elevated in response to chronic antidepressant treatment (29, 30).”
BackgroundPharmacological agents acting at subtypes of metabotropic glutamate receptors
Schoepp, D. D., Jane, D. E., & Monn, J. A. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00092-1 · Cited by 1,060
Neuroprotection by Aspirin and Sodium Salicylate Through Blockade of NF-κB Activation
Grilli, M., Pizzi, M., Memo, M., & Spano, P. (1996) · Science · doi:10.1126/science.274.5291.1383 · Cited by 750
Metabotropic glutamate receptors: From the workbench to the bedside
Nicoletti, F., Bockaert, J., Collingridge, G. L., Conn, P. J., Ferraguti, F., Schoepp, D. D., Wroblewski, J. T., & Pin, J. P. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.10.022 · Cited by 653
Self-citationLinking Molecules to Mood: New Insight Into the Biology of Depression
Krishnan, V., & Nestler, E. J. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.10030434 · Cited by 643
Antidepressant Actions of Histone Deacetylase Inhibitors
Covington, H. E., Maze, I., LaPlant, Q. C., Vialou, V. F., Ohnishi, Y. N., Berton, O., Fass, D. M., Renthal, W., Rush, A. J., Wu, E. Y., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.1758-09.2009 · Cited by 624 · cited 2×
“A role for histone acetylation in the control of Grm2 expression was supported by the use of MS-275, an inhibitor of class I HDACs (21).”
MethodAgomelatine, the first melatonergic antidepressant: discovery, characterization and development
de Bodinat, C., Guardiola-Lemaitre, B., Mocaër, E., Renard, P., Muñoz, C., & Millan, M. J. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3140 · Cited by 593
McEwen, B. S., Chattarji, S., Diamond, D. M., Jay, T. M., Reagan, L. P., Svenningsson, P., & Fuchs, E. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.80 · Cited by 406
Moghaddam, B. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01362-2 · Cited by 392
Clinical Studies of Histone Deacetylase Inhibitors
Prince, H. M., Bishton, M. J., & Harrison, S. J. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2785 · Cited by 356
Neugebauer, V., Galhardo, V., Maione, S., & Mackey, S. C. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2008.12.014 · Cited by 353
Molecular studies of major depressive disorder: the epigenetic perspective
Mill, J., & Petronis, A. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001992 · Cited by 302
HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity
Kurita, M., Holloway, T., García-Bea, A., Kozlenkov, A., Friedman, A. K., Moreno, J. L., Heshmati, M., Golden, S. A., Kennedy, P. J., Takahashi, N., et al. (2012) · Nature Neuroscience · doi:10.1038/nn.3181 · Cited by 285
Bagley, J., & Moghaddam, B. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00435-6 · Cited by 231
Lowy, M. T., Wittenberg, L., & Yamamoto, B. K. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65010268.x · Cited by 217
Chronic mild stress-induced anhedonia: Greater effect in a genetic rat model of depression
Pucilowski, O., Overstreet, D. H., Rezvani, A. H., & Janowsky, D. S. (1993) · Physiology & Behavior · doi:10.1016/0031-9384(93)90351-f · Cited by 216
Synaptosomes Still Viable after 25 Years of Superfusion
Raiteri, L., & Raiteri, M. (2000) · Neurochemical Research · doi:10.1023/a:1007648229795 · Cited by 206
Chiechio, S., Zammataro, M., Morales, M. E., Busceti, C. L., Drago, F., Gereau, R. W., Copani, A., & Nicoletti, F. (2009) · Molecular Pharmacology · doi:10.1124/mol.108.054346 · Cited by 190
Self-citationRobinson, M. (2009) · Frontiers in Bioscience · doi:10.2741/3585 · Cited by 158
Morishima, Y., Miyakawa, T., Furuyashiki, T., Tanaka, Y., Mizuma, H., & Nakanishi, S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500914102 · Cited by 148
Yoshimizu, T., Shimazaki, T., Ito, A., & Chaki, S. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0390-7 · Cited by 139
mGlu2/3 and mGlu5 receptors: Potential targets for novel antidepressants
Chaki, S., Ago, Y., Pałucha-Poniewiera, A., Matrisciano, F., & Pilc, A. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.05.022 · Cited by 125
Self-citationInverse Correlation of Brain and Blood BDNF Levels in a Genetic Rat Model of Depression
Elfving, B., Plougmann, P. H., Müller, H. K., Mathé, A. A., Rosenberg, R., & Wegener, G. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709990721 · Cited by 119 · cited 1×
“Thus the corrective action of LAC on brain and serum BDNF levels is in line with its antidepressant activity in FSL rats, although the precise relationship between BDNF and the depressive-like phenotype of FSL rats is uncertain (31, 32).”
Self-citationGalli, M., Salmoiraghi, S., Golay, J., Gozzini, A., Crippa, C., Pescosta, N., & Rambaldi, A. (2009) · Annals of Hematology · doi:10.1007/s00277-009-0793-8 · Cited by 109
Effects of Carnitine on Fatty-Acid Oxidation by Muscle
Fritz, I. B., & McEwen, B. (1959) · Science · doi:10.1126/science.129.3345.334 · Cited by 104
Jiménez-Vasquez, P. A., Díaz-Cabiale, Z., Caberlotto, L., Bellido-Estévez, I., Overstreet, D. H., Fuxé, K., & Mathé, A. A. (2006) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2006.06.011 · Cited by 102
Self-citationFell, M. J., Witkin, J. M., Falcone, J. F., Katner, J., Perry, K. W., Hart, J. C., Rorick‐Kehn, L. M., Overshiner, C. D., Rasmussen, K., Chaney, S. F., et al. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.172957 · Cited by 99
Restarting Clozapine after Neutropenia
Whiskey, E., & Taylor, D. M. (2007) · CNS Drugs · doi:10.2165/00023210-200721010-00003 · Cited by 93
Zanardi, R., & Smeraldi, E. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.10.005 · Cited by 87
Chiechio, S., Copani, A., Petris, L. D., Morales, M. E. P., Nicoletti, F., & Gereau, R. W. (2006) · Molecular Pain · doi:10.1186/1744-8069-2-20 · Cited by 80
Self-citationChiechio, S., Copani, A., Zammataro, M., Battaglia, G., Gereau, R. W., & Nicoletti, F. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.12.003 · Cited by 76
Self-citationEvaluation of the effects of L-acetylcarnitine on senile patients suffering from depression.
Garzya, G., Corallo, D., Fiore, A., Lecciso, G., Petrelli, G., & Zotti, C. (1990) · PubMed · Cited by 55
Matrisciano, F., Caruso, A., Orlando, R., Marchiafava, M., Bruno, V., Battaglia, G., Gruber, S. H. M., Melchiorri, D., Tatarelli, R., Girardi, P., et al. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.05.014 · Cited by 51
Self-citationYasuhara, A., Nakamura, M., Sakagami, K., Shimazaki, T., Yoshikawa, R., Chaki, S., Ohta, H., & Nakazato, A. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.01.060 · Cited by 43
Tsunoka, T., Kishi, T., Ikeda, M., Kitajima, T., Yamanouchi, Y., Kinoshita, Y., Kawashima, K., Okochi, T., Okumura, T., Inada, T., et al. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.04.007 · Cited by 43
Matrisciano, F., Panaccione, I., Zusso, M., Giusti, P., Tatarelli, R., Iacovelli, L., Mathé, A. A., Gruber, S. H. M., Nicoletti, F., & Girardi, P. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002005 · Cited by 42
Self-citationKovačević, T., Skelin, I., Minuzzi, L., Rosa-Neto, P., & Diksic, M. (2012) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2012.01.010 · Cited by 41
Epigenetics in Suicide and Depression
Autry, A. E., & Monteggia, L. M. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.08.033 · Cited by 38
Bjørnebekk, A., Mathé, A. A., Gruber, S. H. M., & Brené, S. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708008912 · Cited by 30
Self-citationSuicidal Ideation during Antidepressant Treatment: Do Genetic Predictors Exist?
Perroud, N. A. (2011) · CNS Drugs · doi:10.2165/11589420-000000000-00000 · Cited by 25
Effect of hyperammonemia on the levels of carnitine in mice
Costell, M., Míguez, M. P., O’Connor, J., & Grisolía, S. (1987) · Neurology · doi:10.1212/wnl.37.5.804 · Cited by 20
Cited by
Stress Effects on Neuronal Structure: Hippocampus, Amygdala, and Prefrontal Cortex
McEwen, B. S., Nasca, C., & Gray, J. D. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.171 · Cited by 1,574
Self-citationMechanisms of stress in the brain
McEwen, B. S., Bowles, N. P., Gray, J. D., Hill, M. N., Hunter, R. G., Karatsoreos, I. N., & Nasca, C. (2015) · Nature Neuroscience · doi:10.1038/nn.4086 · Cited by 1,386
Self-citationNeurobiological and Systemic Effects of Chronic Stress
McEwen, B. S. (2017) · Chronic Stress · doi:10.1177/2470547017692328 · Cited by 1,059
“An unregulated overflow of glutamate appears to play a role in depressive-like behavior in animal models in which shrinkage of dendrites in the hippocampus and suppression of neurogenesis occurs that can be prevented by upregulation of the metabotrophic glutamate receptor, mGlu2, by agents such as acetyl-L-carnitine a…”
BackgroundThe chronic mild stress (CMS) model of depression: History, evaluation and usage
Willner, P. (2017) · Neurobiology of Stress · doi:10.1016/j.ynstr.2016.08.002 · Cited by 959
An energetic view of stress: Focus on mitochondria
Picard, M., McEwen, B. S., Epel, E. S., & Sandi, C. (2018) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2018.01.001 · Cited by 542
Metadata
- Authors
- Nasca, C., Xenos, D., Barone, Y., Caruso, A., Scaccianoce, S., Matrisciano, F., Battaglia, G., Mathé, A. A., Pittaluga, A., Lionetto, L., Simmaco, M., & Nicoletti, F.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2013-02-04
- Volume
- 110
- Issue
- 12
- Pages
- 4804-4809
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2096726540
- Cited by
- 263
- References
- 48
- FWCI
- 16.72
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.